Herpes Simplex Virus type-1 infection induces synaptic dysfunction in cultured cortical neurons via GSK-3 activation and intraneuronal amyloid-β protein accumulation

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Piacentini, Roberto ^a   Li Puma, Domenica Donatella ^a   Ripoli, Cristian ^a   Marcocci, Maria Elena ^b   De Chiara, Giovanna ^c   Garaci, Enrico ^d   Teresa Palamara, Anna ^b,d   Grassi, Claudio ^a,d  

^a CATHOLIC UNIVERSITY   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c INSTITUTE OF TRANSLATIONAL PHARMACOLOGY   (Italy)

^d IRCCS SAN RAFFAELE PISANA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; GLYCOGEN SYNTHASE KINASE 3; SYNAPSIN; SYNAPTOPHYSIN;

ALZHEIMER DISEASE; ANIMAL; BIOSYNTHESIS; BRAIN CORTEX; GENE EXPRESSION REGULATION; GENETICS; HERPES SIMPLEX VIRUS 1; HUMAN; METABOLISM; MOUSE; NERVE CELL; PATHOGENICITY; PATHOLOGY; RISK FACTOR; SYNAPTIC TRANSMISSION; VIROLOGY;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; CEREBRAL CORTEX; GENE EXPRESSION REGULATION; GLYCOGEN SYNTHASE KINASE 3; HERPESVIRUS 1, HUMAN; HUMANS; MICE; NEURONS; RISK FACTORS; SYNAPSINS; SYNAPTIC TRANSMISSION; SYNAPTOPHYSIN;

EID: 84944916968     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep15444     Document Type: Article

References (60)

1. Selkoe, D. J. Alzheimer's disease. Cold Spring Har. Perspect Biol. 3, 7 (2011).
2. Mancuso, R. et al. Relationship between herpes simplex virus-1-specific antibody titers and cortical brain damage in Alzheimer's disease and amnestic mild cognitive impairment. Front Aging Neurosci 6, 285 (2014).
3. Piacentini, R. et al. HSV-1 and Alzheimer's disease: more than a hypothesis. Front. Pharmacol. 5, 97 (2014).
4. Lövheim, H., Gilthorpe, J., Adolfsson, R., Nilsson, L. G. & Elgh, F. Reactivated herpes simplex infection increases the risk of Alzheimer's disease. Alzheimers Dement In press (2014).
5. Piacentini, R. et al. HSV-1 promotes Ca2+-mediated APP phosphorylation and A accumulation in rat cortical neurons. Neurobiol. Aging 32, 2323.e13-26 (2011).
6. Chang, K. A. et al. Phosphorylation of amyloid precursor protein (APP) at Thr668 regulates the nuclear translocation of the APP intracellular domain and induces neurodegeneration. Mol. Cell. Biol. 26, 4327-4338 (2006).
7. Passer, B. et al. Generation of an apoptotic intracellular peptide by-secretase cleavage of Alzheimer's amyloid protein precursor. J. Alzheimer's. Dis. 2, 289-301 (2000).
8. De Chiara, G. et al. APP processing induced by herpes simplex virus type 1 (HSV-1) yields several APP fragments in human and rat neuronal cells. PLoS One 5, e13989 (2010).
9. Aplin, A. E., Gibb, G. M., Jacobsen, J. S., Gallo, J. M. & Anderton, B. H. In vitro phosphorylation of the cytoplasmic domain of the amyloid precursor protein by glycogen synthase kinase-3. J. Neurochem. 67, 699-707 (1996).
10. Pierrot, N. et al. Calcium-mediated transient phosphorylation of tau and amyloid precursor protein followed by intraneuronal amyloid accumulation. J. Biol. Chem. 281, 39907-39914 (2006).
11. Colombo, A. et al. JNK regulates APP cleavage and degradation in a model of Alzheimer's disease. Neurobiol Dis. 33, 518-525 (2009).
12. Iijima, K. et al. Neuron-specific phosphorylation of Alzheimer's-amyloid precursor protein by cyclin-dependent kinase 5. J. Neurochem. 75, 1085-1091 (2000).
13. Llorens-Marítin, M., Jurado, J., Hernández, F. & Avila, J. GSK-3, a pivotal kinase in Alzheimer disease. Front. Mol. Neurosci. 7, 46 (2014).
14. Phiel, C. J., Wilson, C. A., Lee, V. M. & Klein, P. S. GSK-3 regulates production of Alzheimer's disease amyloid peptides. Nature 423, 435-439 (2003).
15. Takashima, A. GSK-3 is essential in the pathogenesis of Alzheimer's disease. J. Alzheimers Dis. 9 (3 Suppl), 309-317 (2006).
16. Leroy, K., Yilmaz, Z. & Brion, J. P. Increased level of active GSK-3 in Alzheimer's disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration. Neuropathol. Appl. Neurobiol. 33, 43-55 (2007).
17. DaRocha-Souto, B. et al. Activation of glycogen synthase kinase-3 beta mediates-amyloid induced neuritic damage in Alzheimer's disease. Neurobiol. Dis. 45, 425-437 (2012).
18. Rockenstein, E. et al. Neuroprotective effects of regulators of the glycogen synthase kinase-3 signaling pathway in a transgenic model of Alzheimer's disease are associated with reduced amyloid precursor protein phosphorylation. J. Neurosci. 27, 1981-1991 (2007).
19. Oddo, S. et al. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular A and synaptic dysfunction. Neuron 39, 409-421 (2003).
20. Tampellini, D. et al. Internalized antibodies to the A domain of APP reduce neuronal A and protect against synaptic alterations. J. Biol. Chem. 282, 18895-18906 (2007).
21. Moreno, H. et al. Synaptic transmission block by presynaptic injection of oligomeric amyloid. Proc. Natl. Acad. Sci. USA 106, 5901-5906 (2009).
22. Bayer, T. A. & Wirths, O. Intracellular accumulation of amyloid-a predictor for synaptic dysfunction and neuron loss in Alzheimer's disease. Front. Aging Neurosci. 2, 8 (2010).
23. Ripoli, C. et al. Effects of different amyloid-protein analogues on synaptic function. Neurobiol. Aging 34, 1032-1044 (2013).
24. Ripoli, C. et al. Intracellular accumulation of amyloid (A) protein plays a major role in A-induced alterations of glutamatergic synaptic transmission and plasticity. J. Neurosci. 34, 12893-12903 (2014).
25. Jo, J. et al. A (1-42) inhibition of LTP is mediated by a signaling pathway involving caspase-3, Akt1 and GSK-3. Nat. Neurosci. 14, 545-547 (2010).
26. Bradley, C. A. et al. A pivotal role of GSK-3 in synaptic plasticity. Front. Mol. Neurosci. 5, 13 (2012).
27. Smillie, K. J., Cousin, M. A. The Role of GSK3 in Presynaptic Function. Int. J. Alzheimers Dis. 2011, 263673 (2011).
28. Civitelli, L. et al. Herpes simplex virus type 1 infection in neurons leads to production and nuclear localization of APP intracellular domain (AICD): implications for Alzheimers disease pathogenesis. J. Neurovirology In Press (2015).
29. Naghavi, M. H., Gundersen G. G. & Walsh D. Plus-end tracking proteins, CLASPs, and a viral Akt mimic regulate herpesvirusinduced stable microtubule formation and virus spread. Proc. Natl. Acad. Sci. USA 110, 18268-18273 (2013).
30. Hsu, M. J., Wu, C. Y., Chiang, H. H., Lai, Y. L. & Hung, S. L. PI3K/Akt signaling mediated apoptosis blockage and viral gene expression in oral epithelial cells during herpes simplex virus infection. Virus Res. 153, 36-43 (2010).
31. Cuesto, G. et al. GSK3 Inhibition Promotes Synaptogenesis in Drosophila and Mammalian Neurons. PLoS One 10, e0118475 (2015).
32. Tang, M. et al. GSK-3/CREB pathway involved in the gx-50's effect on Alzheimer's disease. Neuropharmacology 81, 256-266 (2014).
33. Fiol, C. J. et al. A secondary phosphorylation of CREB341 at Ser129 is required for the cAMP-mediated control of gene expression. A role for glycogen synthase kinase-3 in the control of gene expression. J. Biol. Chem. 269, 32187-32193 (1994).
34. Saeki, K., Yuo, A. & Takaku, F. Cell-cycle-regulated phosphorylation of cAMP response element-binding protein: identification of novel phosphorylation sites. Biochem. J. 338, 49-54 (1999).
35. Lee, M. S. et al. APP processing is regulated by cytoplasmic phosphorylation. J. Cell. Biol. 16, 83-95 (2003).
36. Bárquez, D. A. & González-Billault, C. The amyloid precursor protein intracellular domain-fe65 multiprotein complexes: a challenge to the amyloid hypothesis for Alzheimer's disease Int. J. Alzheimer's Dis. 2012, 353145 (2012).
37. Kerridge, C., Belyaev, N. D., Nalivaeva, N. N. & Turner, A. J. The A-clearance protein transthyretin, like neprilysin, is epigenetically regulated by the amyloid precursor protein intracellular domain. J. Neurochem. 130, 419-431 (2014).
38. Sun, H. & Chen, Q. M. Inhibitors of GSK-3 prevent corticosterone from inducing COX-1 expression in cardiomyocytes. Cardiovasc. Toxicol. 8, 93-100 (2008).
39. Hartigan, J. A. & Johnson, G. V. Transient increases in intracellular calcium result in prolonged site-selective increases in Tau phosphorylation through a glycogen synthase kinase 3-dependent pathway. J. Biol. Chem. 274, 21395-21401 (1999).
40. Cai, Z., Zhao, Y. & Zhao, B. Roles of glycogen synthase kinase 3 in Alzheimer's disease. Curr. Alzheimer Res. 9, 864-879 (2012).
41. Jaworski, T. et al. GSK-3 / kinases and amyloid production in vivo. Nature 480, E4-5 (2011).
42. Sofola, O. et al. Inhibition of GSK-3 ameliorates A? pathology in an adult-onset Drosophila model of Alzheimer's disease. PLoS Genet 6, e1001087 (2010).
43. Zhu, L. Q. et al. GSK-3 inhibits presynaptic vesicle exocytosis by phosphorylating P/Q-type calcium channel and interrupting SNARE complex formation. J. Neurosci. 30, 3624-3633 (2010).
44. Clayton, E. L. et al. Dynamin I phosphorylation by GSK3 controls activity-dependent bulk endocytosis of synaptic vesicles. Nat. Neurosci. 13, 845-851 (2010).
45. Shavkunov, A. S. et al. The Fibroblast Growth Factor 14: Voltage-gated Sodium Channel Complex Is a New Target of Glycogen Synthase Kinase 3 (GSK3). J Biol. Chem. 288, 19370-19385 (2013).
46. Hsu, W. C. et al. Identifying a kinase network regulating FGF14:Nav1.6 complex assembly using split-luciferase complementation. PLoS One 10, e0117246 (2015).
47. James, T. F. et al. The Na1.2 channel is regulated by GSK3. Biochim. Biophys. Acta 1850, 832-844 (2015).
48. Wildburger, N. C. & Laezza, F. Control of neuronal ion channel function by glycogen synthase kinase-3: new prospective for an old kinase. Front. Mol. Neurosci. 5, 80 (2012).
49. Wilson S. M., Ki Yeon S., Yang X. F., Park K. D. & Khanna R. Differential regulation of collapsin response mediator protein 2 (CRMP2) phosphorylation by GSK3 and CDK5 following traumatic brain injury. Front. Cell. Neurosci. 8, 135 (2014).
50. Zhu, L. Q. et al. Activation of glycogen synthase kinase-3 inhibits long-term potentiation with synapse-associated impairments. J. Neurosci. 27, 12211-12220 (2007).
51. Wozniak, M. A., Frost, A. L. & Itzhaki, R. F. Alzheimer's disease specific tau phosphorylation is induced by herpes simplex virus type 1. J. Alzheimer's Dis. 16, 341-350 (2009).
52. Lasagna-Reeves, C. A. et al. Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice. Mol. Neurodegener. 6, 39 (2011).
53. Lasagna-Reeves, C. A. et al. Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau. Sci. Rep. 2, 700 (2012).
54. Grimes, C. A. & Jope, R. S. The multifaceted roles of glycogen synthase kinase 3 in cellular signaling. Prog. Neurobiol. 65, 391-426 (2001).
55. Alberini, C. M. Transcription factors in long-term memory and synaptic plasticity. Physiol. Rev. 89, 121-145 (2009).
56. Fusco, S. et al. A role for neuronal cAMP responsive-element binding (CREB)-1 in brain responses to calorie restriction. Proc. Natl. Acad. Sci. USA 109, 621-626 (2012).
57. Wozniak, M. A., Itzhaki, R. F., Shipley, S. J. & Dobson, C. B. Herpes simplex virus infection causes cellular-amyloid accumulation and secretase upregulation. Neurosci. Lett. 429, 95-100 (2007).
58. Killington, R. A. & Powell, K. L. Growth, assay and purification of Herpes viruses. In: Virology A Practical Approach (ed. B. W. J. Mahy), pp. 207-236 (Oxford IRL press, 1991).
59. Grassi, C., Magnelli, V., Carabelli, V., Sher, E. & Carbone, E. Inhibition of low-and high-threshold Ca2+ channels of human neuroblastoma IMR32 cells by Lambert-Eaton myasthenic syndrome (LEMS) IgGs. Neurosci Lett. 181, 50-56 (1994).
60. Attar, A. et al. Protection of primary neurons and mouse brain from Alzheimer's pathology by molecular tweezers. Brain 135, 3735-3748 (2012).